| # | Drug | Count |
|---|---|---|
| 0 | LEFLUNOMIDE | 112 |
| 1 | ADALIMUMAB-ADAZ | 110 |
| 2 | SECUKINUMAB | 110 |
| 3 | DICLOFENAC SODIUM | 109 |
| 4 | PREDNISONE | 107 |
| 5 | RITUXIMAB | 106 |
| 6 | DICLOFENAC | 105 |
| 7 | ADALIMUMAB | 103 |
| 8 | ERENUMAB-AOOE | 99 |
| 9 | NAPROXEN SODIUM | 99 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PYRIDOXINE HYDROCHLORIDE | 38 | 0.0150 |
| 1 | SENNOSIDES, STIMULANT LAXATIVE | 1 | 0.0139 |
| 2 | TRIPROLIDINE HYDROCHLORIDE | 2 | 0.0114 |
| 3 | DICLOFENAC POTASSIUM TABLETS | 80 | 0.0100 |
| 4 | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 57 | 0.0099 |
| 5 | MAGNESIUM CITRATE ORAL SOLUTION | 57 | 0.0099 |
| 6 | PROBENECID AND COLCHICINE | 1 | 0.0098 |
| 7 | MAGNESIUM CITRATE | 57 | 0.0097 |
| 8 | DICLOFENAC POTASSIUM | 80 | 0.0077 |
| 9 | PSEUDOEPHEDRINE HCL | 76 | 0.0071 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 136 |
| 1 | Corticosteroid [EPC] | 124 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 115 |
| 3 | Antirheumatic Agent [EPC] | 112 |
| 4 | Interleukin-17A Antagonist [EPC] | 110 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 106 |
| 6 | Vitamin C [EPC] | 102 |
| 7 | Aminosalicylate [EPC] | 92 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 92 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 89 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 82 | 0.0017 |
| 1 | beta3-Adrenergic Agonist [EPC] | 68 | 0.0015 |
| 2 | Antiseptic [EPC] | 6 | 0.0015 |
| 3 | Antirheumatic Agent [EPC] | 112 | 0.0011 |
| 4 | Endoglycosidase [EPC] | 8 | 0.0008 |
| 5 | Aminosalicylate [EPC] | 92 | 0.0007 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 89 | 0.0007 |
| 7 | Histamine-1 Receptor Antagonist [EPC] | 49 | 0.0006 |
| 8 | Interleukin-17A Antagonist [EPC] | 110 | 0.0006 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 76 | 0.0006 |